Pfizer Seeks To Gouge Taxpayers Even Further By Formally Asking To Vaccinate Kids

Pfizer created its vaccine in conjunction with BioNTech.

Pfizer has had a tremendously profitable year so far, posting a nearly $5 billion profit statement in just the first quarter alone. This spike in profits has largely been a result of the sales from the vaccine they developed alongside BioNTech with generous taxpayer grants and subsidies, effectively privatizing the profits and socializing the costs with the full blessing of the Biden regime, a collusion that fits the technical definition of Fascism. But apparently, this record-breaking year is no longer enough for the oligarchs at the $200+ billion medical conglomerate.

According to The Epoch Times, Pfizer has officially requested approval from the relevant health regulators to produce vaccines targeted at children between the ages of five and eleven. While not a shock to those who have been paying attention, this nonetheless represents what many consider to be the next logical step in the march towards a totalitarian globalist dystopia.

“With new cases in children in the U.S. continuing to be at a high level, this submission is an important step in our ongoing effort against COVID-19,” Pfizer said in a statement. What Pfizer seemed to have innocently omitted from their statement is that severe cases of covid amongst late adolescents are exceeded by the side effects of taking the jab, a reality even hard-left news outlets have reluctantly admitted to.

Pfizer and its many government assistants have nonetheless been diligently delivering lip service to the public to convince them that their main priority is and will always be the health and safety of their consumers rather than their quarterly profit statement to their shareholders. Indeed, Dr. Janet Woodcock, the acting commissioner of the FDA, said recently that the vaccine “may need a different dosage or formulation from that used in an older pediatric population or adults.”

“We know from our vast experience with other pediatric vaccines that children are not small adults, and we will conduct a comprehensive evaluation of clinical trial data submitted in support of the safety and effectiveness of the vaccine used in a younger pediatric population,” she said. And if there is one thing the public can be assured of, it’s that Pfizer would never jeopardize the public or its employees to squeeze an extra million(s) in profit.

As of the writing of this article, the FDA’s advisory panel will convene on the 26th of this month to examine the data and to determine whether the public has been conditioned enough to take this next brave step towards totalitarianism whereas the CDC has yet to set a date for their equivalent panel.